Pancreatic Cancer Research

ResearcherQingdao UniversityNo recent work listed

Peng Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0822-700X; OpenAlex author ID A5018569941. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2016: 3 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 3 papers · 2021: 5 papers · 2022: 1 paper · 2023: 1 paper

Papers 15

  1. Factors predicting recurrence after left‑sided pancreatectomy for pancreatic ductal adenocarcinoma. First author DOI 10.1186/s12957-023-03080-z↗
  2. Clinical outcome comparison of laparoscopic radical antegrade modular pancreatosplenectomy vs. laparoscopic distal pancreatosplenectomy for left-sided pancreat… Co-author DOI 10.3389/fsurg.2022.981591↗
  3. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling. Co-author DOI 10.1007/s00432-020-03447-9↗
  4. Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Co-author DOI 10.1038/s41388-021-01960-w↗
  5. The prognostic evaluation of CA19-9, D-dimer and TNFAIP3/A20 in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1097/md.0000000000024651↗
  6. Discovery and Validation of Circulating EVL mRNA as a Prognostic Biomarker in Pancreatic Cancer. Co-author DOI 10.1155/2021/6656337↗
  7. Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma. Co-author DOI 10.18632/aging.202377↗
  8. PLS3 predicts poor prognosis in pancreatic cancer and promotes cancer cell proliferation via PI3K/AKT signaling. Co-author DOI 10.1002/jcp.29685↗
  9. High Expression of COL17A1 Predicts Poor Prognosis and Promotes the Tumor Progression via NF-κB Pathway in Pancreatic Adenocarcinoma. Co-author DOI 10.1155/2020/8868245↗
  10. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer. Co-author DOI 10.7150/thno.49147↗
  11. Identification of lncRNAs and Their Functional Network Associated with Chemoresistance in SW1990/GZ Pancreatic Cancer Cells by RNA Sequencing. Co-author DOI 10.1089/dna.2018.4312↗
  12. The involvement of lncRNAs in the development and progression of pancreatic cancer. Co-author DOI 10.1080/15384047.2017.1385682↗
  13. Long noncoding RNA MIR31HG exhibits oncogenic property in pancreatic ductal adenocarcinoma and is negatively regulated by miR-193b. Co-author DOI 10.1038/onc.2015.430↗
  14. MiR-125a regulates chemo-sensitivity to gemcitabine in human pancreatic cancer cells through targeting A20. Co-author DOI 10.1093/abbs/gmv129↗
  15. CIP2A down regulation enhances the sensitivity of pancreatic cancer cells to gemcitabine. Co-author DOI 10.18632/oncotarget.7447↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie J. Yao · 10 shared papers, 2016–2021 · strength 1.12
  2. Jianjun Qian · 7 shared papers, 2016–2021 · strength 0.74
  3. Zechang Xin · 5 shared papers, 2020–2021 · strength 0.66
  4. Yan Du · 5 shared papers, 2020–2021 · strength 0.66
  5. Feiyu Mao · 5 shared papers, 2020–2021 · strength 0.66
  6. Zhennan Li · 7 shared papers, 2016–2021 · strength 0.66
  7. Duguang Li · 4 shared papers, 2017–2020 · strength 0.39
  8. Yucheng Zhou · 2 shared papers, 2022–2023 · strength 0.32
  9. Weiwei Jin · 2 shared papers, 2022–2023 · strength 0.32
  10. Yiping Mou · 2 shared papers, 2022–2023 · strength 0.32
  11. Fengyu Xu · 2 shared papers, 2020–2021 · strength 0.19
  12. Gang Zhao · 2 shared papers, 2020–2021 · strength 0.19
  13. Zhu Zeng · 2 shared papers, 2020–2021 · strength 0.19
  14. Yuhang Hu · 2 shared papers, 2020–2021 · strength 0.19
  15. Chunyou Wang · 2 shared papers, 2020–2021 · strength 0.19
  16. Yuanyu Wang · 1 shared paper, 2023 · strength 0.17
  17. Yunyun Xu · 1 shared paper, 2023 · strength 0.17
  18. Tao Xia · 1 shared paper, 2023 · strength 0.17
  19. Aman Xu · 1 shared paper, 2021 · strength 0.16
  20. Qingbo Feng · 1 shared paper, 2021 · strength 0.15
  21. Nan Niu · 1 shared paper, 2022 · strength 0.15
  22. Tao Xia · 1 shared paper, 2022 · strength 0.15
  23. Yunyun Xu · 1 shared paper, 2022 · strength 0.15
  24. Ye Zeng · 1 shared paper, 2021 · strength 0.10
  25. Shuai Zhu · 1 shared paper, 2021 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.